APOLLOMICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.201 USD | -2.24% |
|
-6.51% | -79.17% |
| 04/06 | Apollomics Announces Vebreltinib Data At the 2024 American Society of Clinical Oncology Annual Meeting | CI |
| 08/05 | Apollomics, Inc. Appoints Robert Lin to the Board of Directors | CI |
c2c427c29b6c39ec015b1a8f49c9.m5u3vcul9Qx8tyY4FdD-f5TJEVwxwlnh8JRSVB1M7Ys.raiP84zHwl4S_3lSXISnC_KNSxZo9x-bweQLFWdhjuL59NvNm8eBPi70cw~804f3ce70d220c2fcfa38ac5bfe54ff8
